LIANBIO's ticker is and the CUSIP is 53000N108. A total of 30 filers reported holding LIANBIO in Q4 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,282,084 | $8,467,000 | 4.92% |
| Perceptive Advisors | 56,319,960 | $208,947,000 | 4.18% |
| VR Adviser, LLC | 5,378,341 | $19,954,000 | 3.23% |
| SCHF (GPE), LLC | 937,500 | $3,478,000 | 1.08% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,314,173 | $12,296,000 | 0.73% |
| RA Capital Management | 7,655,015 | $28,400,000 | 0.62% |
| Logos Global Management LP | 412,837 | $1,532,000 | 0.20% |
| Affinity Asset Advisors, LLC | 325,000 | $1,206,000 | 0.19% |
| SPHERA FUNDS MANAGEMENT LTD. | 275,007 | $1,020,000 | 0.14% |
| MYDA Advisors LLC | 86,000 | $319,000 | 0.13% |